Company news

Marinomed Biotech AG news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Ad-hoc: Marinomed Biotech AG files for court restructuring proceedings without self-administration

July 22, 2026

Ad-hoc: Marinomed Biotech AG plans to apply for court restructuring proceedings without self-administration

July 16, 2026

Marinomed Biotech AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution

June 29, 2026

Statement pursuant to § 87 Abs.2 AktG - Thomas Stümmler (87 declaration Thomas Stuemmler E)

May 21, 2026

Form for proxy to IVA (2026 Vollmacht IVA EN FINAL)

May 20, 2026

Marinomed Biotech AG Announces Strategic Partnership and Worldwide Licensing for Marinosolv® Technology in Inhalation Therapy

May 19, 2026

Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding Market

May 11, 2026

Marinomed Announces Strategic Expansion into Compounding Services Featuring Marinosolv® Technology

April 22, 2026

Marinomed Biotech AG: Release of a Financial report

April 22, 2026

Marinomed secures financing through successful capital increase

April 13, 2026

Decks

The 5 newest of 31 decks. Every deck is listed under its year.